DICERNA PHARMACEUTICALS INC's ticker is DRNA and the CUSIP is 253031108. A total of 58 filers reported holding DICERNA PHARMACEUTICALS INC in Q4 2015. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $8,000 | -52.9% | 2,889 | 0.0% | 0.00% | – |
| Q3 2016 | $17,000 | +112.5% | 2,889 | +11.9% | 0.00% | – |
| Q2 2016 | $8,000 | -97.2% | 2,582 | -95.1% | 0.00% | – |
| Q1 2016 | $284,000 | -54.0% | 52,917 | +1.8% | 0.00% | -100.0% |
| Q4 2015 | $617,000 | +44.8% | 51,961 | +0.1% | 0.00% | 0.0% |
| Q3 2015 | $426,000 | -42.6% | 51,886 | -2.5% | 0.00% | 0.0% |
| Q2 2015 | $742,000 | +195.6% | 53,197 | +408.7% | 0.00% | – |
| Q1 2015 | $251,000 | +42.6% | 10,458 | -2.2% | 0.00% | – |
| Q4 2014 | $176,000 | +29.4% | 10,695 | 0.0% | 0.00% | – |
| Q3 2014 | $136,000 | -44.0% | 10,695 | -0.6% | 0.00% | – |
| Q2 2014 | $243,000 | -12.6% | 10,760 | +9.3% | 0.00% | – |
| Q1 2014 | $278,000 | – | 9,844 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 1,355,392 | $29,859,000 | 6.21% |
| Bain Capital Life Sciences Investors, LLC | 3,080,237 | $67,858,000 | 4.26% |
| DAFNA Capital Management LLC | 587,756 | $12,948,000 | 3.85% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 227,388 | $5,009,000 | 2.91% |
| RTW INVESTMENTS, LP | 7,253,857 | $159,802,000 | 2.68% |
| Parkman Healthcare Partners LLC | 331,513 | $7,303,000 | 1.87% |
| Evolutionary Tree Capital Management, LLC | 60,864 | $1,341,000 | 1.02% |
| Eagle Health Investments LP | 69,000 | $1,520,000 | 0.97% |
| Woodline Partners LP | 1,358,796 | $29,934,000 | 0.79% |
| Affinity Asset Advisors, LLC | 40,000 | $881,000 | 0.47% |